Preparation and use of immunoconjugates
AssigneeImmunomedics, Inc.
InventorsHans J. Hansen, Shui-on Leung, Jerry Shevitz, Gary L. Griffiths, Seregulam V. Govindan
Life of this patent
Estimating the term…
Loading patent…
AssigneeImmunomedics, Inc.
InventorsHans J. Hansen, Shui-on Leung, Jerry Shevitz, Gary L. Griffiths, Seregulam V. Govindan
Estimating the term…
The present invention relates to immunoconjugates comprising an antibody fragment which is covalently bound to a diagnostic or therapeutic principle through a carbohydrate moiety in the light chain variable region of the antibody fragment. The invention also relates to immunoconjugates comprising an antibody moiety that is an intact antibody containing a glycosylation site in the light chain variable domain which has been introduced into the antibody by mutating the nucleotide sequence encoding the light chain. The resultant immunoconjugates retain the immunoreactivity of the antibody fragment or intact antibody, and target the diagnostic or therapeutic principle to a target tissue where the diagnostic or therapeutic effect is realized. Thus, the invention contemplates the use of such immunoconjugates for diagnosis and immunotherapy. The invention further relates to methods for preparing such immunoconjugates.
A soluble immunoconjugate, comprising:
A soluble immunoconjugate comprising:
A method for preparing an immunoconjugate, comprising covalently binding a loaded polyamidoamine dendrimer carrier to the carbohydrate moiety of an antibody fragment,
A method for preparing an immunoconjugate, comprising covalently binding at least one chelator to the carbohydrate moiety of an antibody fragment,
Dependencies are inferred from the claim text.